Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Efficacy and safety of transcatheter arterial embolization combined with ablation and regorafenib for unresectable hepatocellular carcinoma patients failing first-line treatment: a real-world study.
Journal: Journal of gastrointestinal oncology
Published: April 29, 2025
The effects of a solution-focused model discharge readiness coaching intervention on the parents of Chinese pediatric liver transplantation patients: a single-center observational study.
Journal: Translational pediatrics
Published: January 25, 2025
Comparison of various liver cancer staging systems in predicting prognosis after initial transcatheter arterial chemoembolization: a retrospective study from China.
Journal: Journal of gastrointestinal oncology
Published: November 06, 2024
The Effects of Alfapump on Ascites Control and Quality of Life in Patients With Cirrhosis and Recurrent or Refractory Ascites.
Journal: The American journal of gastroenterology
Published: July 16, 2024
Identification of a prognostic disulfidptosis-related gene signature in hepatocellular cancer.
Journal: Journal of gastrointestinal oncology
Published: July 09, 2024
NOVA2 regulates the properties of liver cancer stem cells and lenvatinib resistance in hepatocellular carcinoma via the Wnt pathway.
Journal: Journal of gastrointestinal oncology
Published: March 08, 2024
Novel Innovations in Ascites Management.
Journal: South Dakota medicine : the journal of the South Dakota State Medical Association
Published: March 10, 2023
A multi-center retrospective study on the efficacy and safety of regorafenib vs. regorafenib combined with PD-1 inhibitors as a second-line therapy in patients with advanced hepatocellular carcinoma.
Journal: Annals of translational medicine
Published: October 31, 2022
Identification of the hsa_circ_0039466/miR-96-5p/FOXO1 regulatory network in hepatocellular carcinoma by whole-transcriptome analysis.
Journal: Annals of translational medicine
Published: May 07, 2022
Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma.
Journal: Annals of translational medicine
Published: February 22, 2022
World Hepatitis Day - We need to call for Action in South Dakota.
Journal: South Dakota medicine : the journal of the South Dakota State Medical Association
Published: August 30, 2021
Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer.
Journal: Annals of translational medicine
Published: February 08, 2021
Last Updated: 09/26/2026